chrX-33020189-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BS2_Supporting
The ENST00000357033.9(DMD):āc.43G>Cā(p.Asp15His) variant causes a missense change. The variant allele was found at a frequency of 0.0000111 in 1,172,799 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.000054 ( 0 hom., 2 hem., cov: 23)
Exomes š: 0.0000066 ( 0 hom. 0 hem. )
Consequence
DMD
ENST00000357033.9 missense
ENST00000357033.9 missense
Scores
3
11
2
Clinical Significance
Conservation
PhyloP100: 5.86
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
BS2
High Hemizygotes in GnomAd4 at 2 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMD | NM_004006.3 | c.43G>C | p.Asp15His | missense_variant | 2/79 | ENST00000357033.9 | NP_003997.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.43G>C | p.Asp15His | missense_variant | 2/79 | 1 | NM_004006.3 | ENSP00000354923 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000536 AC: 6AN: 111947Hom.: 0 Cov.: 23 AF XY: 0.0000586 AC XY: 2AN XY: 34155
GnomAD3 genomes
AF:
AC:
6
AN:
111947
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
34155
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000615 AC: 1AN: 162617Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 52013
GnomAD3 exomes
AF:
AC:
1
AN:
162617
Hom.:
AF XY:
AC XY:
0
AN XY:
52013
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000660 AC: 7AN: 1060852Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 332594
GnomAD4 exome
AF:
AC:
7
AN:
1060852
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
332594
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000536 AC: 6AN: 111947Hom.: 0 Cov.: 23 AF XY: 0.0000586 AC XY: 2AN XY: 34155
GnomAD4 genome
AF:
AC:
6
AN:
111947
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
34155
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 12, 2015 | The p.Asp15His variant in DMD has not been previously reported in individuals wi th cardiomyopathy and was absent from large population studies. Computational pr ediction tools and conservation analysis suggest that the variant may not impact the protein, though this information is not predictive enough to rule out patho genicity. In summary, the clinical significance of the p.Asp15His variant is unc ertain. - |
Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 21, 2020 | - - |
Duchenne muscular dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 19, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DMD protein function. ClinVar contains an entry for this variant (Variation ID: 228589). This variant has not been reported in the literature in individuals affected with DMD-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change replaces aspartic acid, which is acidic and polar, with histidine, which is basic and polar, at codon 15 of the DMD protein (p.Asp15His). - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2023 | The p.D15H variant (also known as c.43G>C), located in coding exon 2 of the DMD gene, results from a G to C substitution at nucleotide position 43. The aspartic acid at codon 15 is replaced by histidine, an amino acid with similar properties. This variant has been detected in a cohort referred for dilated cardiomyopathy genetic testing (Mazzarotto F et al. Circulation. 2020 Feb;141(5):387-398). Based on data from gnomAD, the C allele has an overall frequency of 0.001084% (2/184470) total alleles studied, with 0 hemizygotes observed. The highest observed frequency was 0.01136% (2/17607) of African American alleles. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T;.;.;.;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;D;T;T;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
T;T;T;T;T;T;T
MetaSVM
Pathogenic
D
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;D;.;D;N;D;D
REVEL
Uncertain
Sift
Uncertain
.;D;.;D;D;D;T
Sift4G
Uncertain
D;D;D;D;D;D;D
Polyphen
1.0, 0.87
.;D;.;.;.;.;P
Vest4
MutPred
0.33
.;.;Gain of MoRF binding (P = 0.0648);Gain of MoRF binding (P = 0.0648);Gain of MoRF binding (P = 0.0648);Gain of MoRF binding (P = 0.0648);.;
MVP
MPC
0.066
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at